Raymond James Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115M Buy
1,350,706
+88,629
+7% +$7.9M 0.04% 459
2025
Q4
$99.7M Sell
1,262,077
-249,169
-16% -$19.5M 0.03% 505
2025
Q3
$121M Buy
1,511,246
+37,026
+3% +$3.16M 0.04% 432
2025
Q2
$134M Sell
1,474,220
-63,768
-4% -$5.82M 0.05% 371
2025
Q1
$144M Buy
1,537,988
+81,551
+6% +$7.3M 0.05% 323
2024
Q4
$132M Buy
+1,456,437
New +$139M 0.05% 346

Other funds holding CL

Raymond James Financial's CL Position: Q1 2026 in Review

Raymond James Financial increased its Colgate-Palmolive (CL) stake by 7% in Q1 2026, buying an estimated $7.9M and bringing the position to 1,350,706 shares worth $115M. The position accounts for 0.04% of the portfolio, ranked #459.

Raymond James Financial first reported a position in CL in Q4 2024 and has held it in 6 quarters since. The position peaked at $144M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Raymond James Financial held 1,350,706 shares of Colgate-Palmolive worth $115M as of Q1 2026.
  • Raymond James Financial bought 88,629 Colgate-Palmolive shares in Q1 2026, an estimated $7.9M.
  • Colgate-Palmolive made up 0.04% of Raymond James Financial's portfolio in Q1 2026, its #459 holding.
  • Raymond James Financial first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Colgate-Palmolive position peaked at $144M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.